191
Views
11
CrossRef citations to date
0
Altmetric
Original Article

Cardioprotective effects of ozone oxidative preconditioning in an in vivo model of ischemia/reperfusion injury in rats

, , , &
Pages 345-354 | Received 25 Oct 2011, Accepted 22 Jan 2012, Published online: 06 Aug 2012

References

  • Laskey WK. Brief repetitive ballon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study. Catheter Cardiovasc Interv 2005;65:361–7.
  • Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124–36.
  • Schott RJ, Rohmann S, Braun ER, Schaper W. Ischemic preconditioning reduces infarct size in swine myocardium. Circ Res 1990;66:1133–42.
  • Toosy N, McMorris EL, Grace PA, Mathie RT. Ischemic preconditioning protects the rat kidney from reperfusion injury. BJU Int 1999;84:489–94.
  • Yellon DM, Hausenloy DJ. Mechanisms of disease. Myocardial reperfusion injury. N Eng J Med 2007;357:1121–35.
  • Park KM, Chen A, Bonventre JV. Prevention of kidney ischemia/reperfusion-induced functional injury and JNK, p38, and MAPK kinase activation by remote ischemic pretreatment. J Biol Chem 2001;276:11870–6.
  • Vaage J, Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg 2003;75:709–14.
  • Borrego A, Zamora ZB, González R, Romay C, Menéndez S, Hernández F, Montero T, Rojas E. Protection by ozone preconditioning is mediated by the antioxidant system in cisplatin-induced nephrotoxicity in rats. Mediators Inflamm 2004;13:13–9.
  • Romero A, Menéndez S, Gómez M, Ley J. Ozone therapy in the advanced stages of arteriosclerosis obliterans. Angiologia 1993;45:146–8.
  • Hernandez F, Menendez S, Wong R. Decrease of blood cholesterol and stimulation of antioxidative response on cardiopathy patients treated with endovenous ozone therapy. Free Rad Biol Med 1995;19:115–9.
  • Barber E, Menéndez S, León OS, Barber MO, Merino N, Calunga JL, Cruz E, Bocci V. Prevention of renal injury after induction of ozone tolerance in rats submitted to warm ischemia. Mediators Inflamm 1999;8:37–41.
  • Chen H, Xing B, Liu X, Zhan B, Zhou J, Zhu H, Chena Z. Similarities between ozone oxidative preconditioning and ischemic preconditioning in renal ischemia/reperfusion injury. Arch Med Res 2008;39:169–78.
  • Bocci V. Ozone as Janus: this controversial gas can be either toxic or medically useful. Mediators Inflamm 2004;13:3–11.
  • Re L, Mawsouf MN, Menéndez S, León OS, Sánchez GM, Hernández F. Ozone therapy: clinical and basic evidence of its therapeutic potential. Arch Med Res 2008;39:19–26.
  • León OS, Menéndez S, Merino N, Castillo R, Sam S, Pérez L, Cruz E, Bocci V. Ozone oxidative preconditioning: a protection against cellular damage by free radicals. Mediators Inflamm 1998;7:289–94.
  • Peralta C, León OS, Xaus C, Prats N, Candelario-Jalil E, Sala-Planell E, Puig-Parellada P, Gelpí E, Roselló-Catafau J. Protective effect of ozone treatment on the injury associated with hepatic ischemia-reperfusion: antioxidant-prooxidant balance. Free Rad Res 1999;31:191–6.
  • Candelario-Jalil E, Mohammed-Al-Dalain S, Fernandez OS. Oxidative preconditioning affords protection against carbon tetrachloride-induced glycogen depletion and oxidative stress in rats. J Appl Toxicol 2001;21:297–301.
  • Bocci V. Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases. Med Hypotheses 1996;46:150–4.
  • Peralta C, Xaus C, Bartrons R, León OS, Gelpí E, Roselló-Catafau J. Effect of ozone treatment on reactive oxygen species and adenosine production during hepatic ischemia-reperfusion. Free Rad Res 2000;33:595–605.
  • Ajamieh H, Merino N, Candelario-jalil E, Menéndez S, Martinez-sanchez G, Re L, Giuliani A, Leon OS. Similar protective effect of ischaemic and ozone oxidative preconditionings in liver ischaemia/reperfusion injury. Pharmacol Res 2002;45:333–9.
  • Sahna E, Parlakpinar H, Turkoz Y, Acet A. Protective effects of melatonin on myocardial ischemia-reperfusion induced infarct size and oxidative changes. Physiol Res 2005;54:491–5.
  • Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Janse MJ. The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. Cardiovasc Res 1988;22:447–55.
  • Curtis MJ, Walker MJA. Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional ischaemia. Cardiovasc Res 1988;22: 656–65.
  • Miranda KM, Espey MG, Wink DA. A rapid, simple spectrophotometric method for simultaneous detection of nitrate and nitrite. Nitric oxide Biol Chem 2001;5:62–71.
  • Noll F. L-(+)-Lactate. In: Bergmeyer HU, editor. Methods of enzymatic analysis, 3rd ed. Weinheim, Germany: VCH-Verlagsgesellschaft, 1985. pp. 582–8.
  • Teerlink T, Hennekes M, Bussemaker J, Groeneveld J. Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high-performance liquid chromatography. Anal Biochem 1993;214:278–83.
  • Hermes-Lima M, Willmore WG, Storey KB. Quantification of lipid peroxidation in tissue extracts based on Fe(III)xylenol orange complex formation. Free Rad Biol Med 1995; 19:271–80.
  • Beutler E, Duron O, Kelly BM. Improved method for the determination of blood glutathione. J Lab Clin Med 1963;61:882–8.
  • Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206–09.
  • Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev 2003;83:1113–51.
  • Reddy HK, Koshy SKG, Shukia H. Triggers and promoters of ischaemic preconditioning. Cardiovasc Res 2002;56:1–3.
  • Hearse DJ, Tosaki A. Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to reperfusion-induced arrhythmias in the rat heart. Mol Cell Cardiol 1988;20:213–23.
  • Cascio WE, Johnson TA, Gettes LS. Electrophysiologic changes in ischemic ventricular myocardium: influence of ionic, metabolic and energetic changes. Cardiovasc Electrophysiol 1995;11:1039–62.
  • Zipes DP. Mechanisms of clinical arrhythmias. Cardiovasc Electrophysiol 2003;14:902–12.
  • Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovas Res 2000;47:446–56.
  • Qu F, Qin XQ, Cui YR, Xiang Y, Tan YR, Liu HJ, Peng LH, Zhou XY, Liu C, Zhu XL. Ozone stress down-regulates the expression of cystic fibrosis transmembrane conductance regulator in human bronchial epithelial cells. Chem Biol Interact 2009;179:219–26.
  • Peuhkurinen KJ. Ischemic heart disease at the cellular level. IJBEM 2000;2:1–8.
  • Gustafsson AB, Gottlieb RA. Heart mitochondria: gates of life and death. Cardiovasc Res 2008;77:334–43.
  • Mani K. Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Failure Rev 2008;13:193–209.
  • Jaeschke H, Farhood A, Smith CW. Neutrophils contribute to ischaemia/reperfusion injury on rat liver in vivo. FASEB J 1990;4:3355–9.
  • Guven A, Uysal B, Akgul O. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 2008; 30:747–54.
  • Tunc T, Uysal B, Atabek C, Kesik V, Caliskan B, Oztas E, Ersoz N, Oter S, Guven A. Erdosteine and ebselen as useful agents in intestinal ischemia/reperfusion injury. J Surg Res 2008;155:210–6.
  • Zweier JL, Talukder MAH. The role of oxidants and free radicals in reperfusion injury. Cardiovasc Res 2006;70:181–90.
  • Godber BLJ, Doel JJ, Sapkota GP. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. Biol Chem 2000;275:7757–63.
  • Kitakaze M, Node K, Takashima S. Role of cellular acidosis in production of nitric oxide in canine ischemic myocardium. J Mol Cell Cardiol 2001;33:1727–37.
  • Beckman JS, Koppenol WH. Nitric oxide, superoxide and peroxynitrite: the good, the bad, and ugly. Am J Physiol Cell Physiol 1996;271:C1424–37.
  • Clementi E, Brown GC, Feelisch M, Moncada S. Persistent inhibition of cell respiration by nitric oxide: crucial role of S-nitrosylation of mitochondrial complex I and protective action of glutathione. Proc Natl Acad Sci 1998;95:7631–6.
  • Thornberry NA, Lazebnik Y. Caspases: enemies within. Science 1998;281:1312–5.
  • Guven A, Gundogdua G, Vurucub S, Uysalc B, Oztasd E, Ozturka H, Korkmazc A. Medical ozone therapy reduces oxidative stress and intestinal damage in an experimental model of necrotizing enterocolitis in neonatal rats. J Pediatr Surg 2009;44:1730–5.
  • Canning BJ, Hmieleski RR, Spannhake EW, Jakab GJ. Ozone reduces murine alveolar and peritoneal macrophage phagocytosis: the role of prostanoids. Am J Physiol 1991;261:277–82.
  • Novelli GP. Role of free radicals in septic shock. J Physiol Pharmacol 1997;48:517–27.
  • Al-Dalaina SM, Martíneza G, Candelario-Jalila E, Menéndezb S, Rec L, Giulianid A, Leóna OS. Ozone treatment reduces markers of oxidative and endothelial damage in an experimental diabetes model in rats. Pharmacol Res 2001;44:391–6.
  • Zweier JL, Flaherty JT, Weisfeldt ML. Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci 1987;84:1404–7.
  • Ambrosio G, Flaherty JT, Duilio C. Oxygen radicals generated at reflow induce peroxidation of membrane lipids in reperfused hearts. J Clin Invest 1991;87:2056–66.
  • Verbunt R, Van der Laarse A. Glutathione metabolism in non-ischemic and postischemic rat hearts in response to an exogenous prooxidant. Mol Cell Biochem 1997;167: 127–34.
  • Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischemia and reperfusion. Biochem J 2005;390:377–94.
  • Jennings RB, Reimer KA, Steenbergen C. Effect of inhibition of the mitochondrial ATPase on net myocardial ATP in total ischemia. J Mol Cell Cardiol 1991;23:1383–95.
  • Ylitalo K, Ala Rami A, Vuorinen K, Peuhkurinen K, Lepojarvi M, Kaukoranta P, Kiviluoma K, Hassinen I. Reversible ischaemic inhibition of F1F0-ATPase in rat and human myocardium. Biochim Biophys Acta 2001;1504:329–39.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.